Effects of alopecia on body image and quality of life of Turkish cancer women with or without headscarf
Faculty of Health Sciences, Trakya University, Aysekadin Kampus, Edirne, Turkey. Supportive Care in Cancer
(Impact Factor: 2.36).
12/2011; 20(10):2349-56. DOI: 10.1007/s00520-011-1338-y
The aim of this study was to find out the effects of chemotherapy-related alopecia on body image and quality of life of Turkish women who have cancer with or without headscarves and factors affecting them.
This descriptive study was conducted with 204 women who received chemotherapy at the Istanbul University Institute of Oncology, Turkey. The Patient Description Form, Body Image Scale and Nightingale Symptom Assessment Scale were used in data collection. Statistical analyses were performed using descriptive statistics and non-parametric tests. Logistic regression analysis was done to predict the factors affecting body image and quality of life of the patients.
No difference was found between women wearing headscarves and those who did not in respect of their body image. However, women who wore headscarves who had no alopecia felt less dissatisfied with their scars, and women not wearing headscarves who had no alopecia have been feeling less self-conscious, less dissatisfied with their appearance. There was difference in terms of quality of life: women wearing headscarves had worse physical, psychological and general well-being than others.
Although there were many important factors, multivariate analysis showed that for body image, having alopecia and wearing headscarves; and for quality of life, having alopecia were the variables that had considerable effects.
Available from: Gulbeyaz Can
- "Body image changes were quantified using four numeric responses; namely " not at all " , 0; " a little " , 1; " quite a bit " , 2; " very much " , 3. The scores for the ten items were then summed to produce an overall score for each patient, ranging from 0 to 30, with zero scores representing no symptoms or distress and higher scores representing increasing symptoms or distress or more body-image concerns (Hopwood et al., 2001). Cronbach's a coefficient of the scale was previously reported as 0.89, and correlation coefficients were between 0.59 and 0.72 (Erol et al., 2011). "
[Show abstract] [Hide abstract]
The effect of alopecia on men and women has not been fully documented in the literature, especially for Turkish cancer patients. The aim of this study was to determine the incidence of chemotherapy-related alopecia and how it affects the body image and quality of life of Turkish male and female cancer patients, in order to identify variables that may be important in the perception of this problem.
This descriptive study was carried out between November 2010 and June 2011 at Istanbul University Institute of Oncology; 201 men and 204 women attended. A face-to-face interview was performed during chemotherapy, and the effects of alopecia on cancer patients were assessed using the Patient Information Form, Body Image Scale, and Nightingale Symptom Assessment Scale.
The study group consisted of 55.1% female and 44.9% male patients. Most of the patients experienced partial or total alopecia during chemotherapy. There were no differences between men and women with regard to body image in respect of degree of alopecia, but the body image of the male and female patients who had partial or complete alopecia was lower than that in patients who had no alopecia; psychological well-being of women was lower than that in men, because the incidence of alopecia was higher in women.
This study contributes new knowledge on the cultural characteristics of Turkish patients, which may assist other researchers working with different international populations. Alopecia is a difficult side effect for both men and women. Health professionals should assess and educate patients differently from the current standard.
European journal of oncology nursing: the official journal of European Oncology Nursing Society 08/2012; 17(3). DOI:10.1016/j.ejon.2012.06.003 · 1.43 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: This article describes the experience of chemotherapy-induced alopecia. Data resulted from an ongoing study, which sought to explore the experience of Australian women with a primary diagnosis of ovarian cancer. Phenomenological analysis of written accounts or interviews with 15 Australian women resulted in 13 of these 15 women giving priority to describing their experience of alopecia. The women described alopecia as the most distressing corporeal feature of the ovarian cancer experience. Factors which contributed to women's distress included: loss of sense of self and altered body image; reminder of their illness and potential for an early death; public statement about their private life, practical issues and re-growth. No literature was located, worldwide, which specifically explores the experience of alopecia for women with ovarian cancer. This article presents the first in-depth exploration of the experience of alopecia for Australian women with ovarian cancer. Insight gained from this study will inform understanding of the issues associated with alopecia for women with ovarian cancer and may facilitate the provision of optimal supportive care provided by health care professionals for female cancer patients with chemotherapy-induced alopecia.
European Journal of Cancer Care 03/2013; 22(4). DOI:10.1111/ecc.12056 · 1.56 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: Diminished hair diameter has been suggested as an early indicator of androgenic alopecia. The objective of the present work is to examine hair diameter changes after appropriate treatments in patients with androgenic alopecia, considering other possible interfering factors such as sex, natural hair color and location of hair sampling on the scalp. In a cross-sectional, case-control setting, 41 patients with androgenic alopecia (the case group) and 41 age and sex-matched healthy individuals (the control groups) were recruited from a referral dermatological center in Tabriz from September 2008 to December 2011. Patients received standard treatments for six months. Hair diameter was measured using a standard digital micrometer (Mitutoyo 0.001 mm, Japan) at baseline and six months later in both groups. In the case group, the mean hair diameter increased significantly from 0.052±0.008 to 0.055±0.008 m, 6 months later (p = 0.03). In the control group, the change of the mean hair diameter was not statistically significant in the controls. Frontal hairs were the While the mean hair diameter in female patients was higher, the mean change of hair diameter after treatment was significantly more in male patients. The mean hair diameter was significantly higher in light-brown than in dark-brown hairs of the patient's thinnest samples, in this study. In conclusion, although hair diameter increased significantly after treatment, other factors such as gender, hair color and location on the scalp may also play significant roles in this regard.
Journal of Medical Sciences(Faisalabad) 02/2014; 14(2):97-100. DOI:10.3923/jms.2014.97.100
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.